Pharmaceutical composition
AssigneeCPEX Pharmaceuticals, Inc.
InventorRobert J. Gyurik
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising: (A) an androgen; (B) a cyclic enhancer of the type used in the compositions and methods claimed by U.S. Pat. No. 5,023,252 to Hsieh; and (C) a thickening agent; including, for example, a composition in which the cyclic enhancer is a macrocyclic ester or a macrocyclic ketone; the use of the composition to treat a condition, for example, male hypogonadism, in a patient by applying the composition to the membrane of the patient; and a method for making the composition.
Claims8
A method for maintaining a therapeutically effective concentration of testosterone in the blood serum of a male for treating hypogonadism which comprises transdermally delivering to the male by applying to the skin a composition which is in the form of a topical gel, which has a viscosity of about 2000 to about 6000 cps and a pH of about 4 to about 8, and comprises:
- (A) about 0.1 to about 5 wt. % of testosterone;
- (B) about 0.5 to about 25 wt. % of oxacyclohexadecan-2-one;
- (C) about 1 to about 6 wt. % of a thickening agent;
- (D) a mixture of solvents which include:
- (i) about 60 to about 75 wt. % of ethanol or isopropanol;
- and (ii) propylene glycol and glycerin as co-solvents.
Dependencies are inferred from the claim text.